Bridgebio Investment Portfolios

Companies
Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) CEO Sells 31,543 Shares Feb 20, 2025
Pharmaceuticals
BridgeBio Pharma Reveals Long-Term Efficacy Data for Acoramidis at AHA Scientific Sessions Oct 3, 2024